CiteFacts · FDA Drug Shortages · FDA source
Pentostatin Injection
Status
FDA currently lists this ingredient in shortage.
This is nationwide FDA status, not local pharmacy inventory. CiteFacts does not provide medical, treatment, substitution, or dosing advice.
FDA package and manufacturer records
| Company | Presentation | FDA availability field | FDA update |
|---|---|---|---|
| Hospira, Inc., a Pfizer Company | Nipent, Injection, 10 mg, single dose vial (NDC 0409-0801-01) | Unavailable | 2026-08-27 |
Source facts
Grouped generic ingredient: Pentostatin Injection · 1 package records · Latest FDA row update: 2026-08-27
Therapeutic categories: Oncology
Dosage forms: Injection
Routes: INTRAVENOUS
Open FDA source data · JSON · Markdown
FDA is authoritative. Source retrieved 2026-08-28T02:58:09+00:00. Derived grouping is documented in this record's derivations.